Repare Therapeutics Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Repare Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Repare Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $112M, a 15% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $112M +$14.5M +15% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $97M +$34.4M +55% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $62.6M +$27.2M +77.1% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $35.4M +$20.9M +145% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $14.4M Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.